VivoSim Labs VIVS
NASDAQ VIVS
$0.16 +0.00 (+1.34%)
As of: Oct 19, 2026 · 3:56 PM EDT

VivoSim Labs (VIVS) Depreciation & Amortization (CF) (2011 - 2026)

Updated

VivoSim Labs' Depreciation & Amortization (CF) came in at $40,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 34.4% from $61,000 a year earlier and down 7.0% from the prior quarter.

Analysis

VivoSim Labs (VIVS) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, VivoSim Labs reported Depreciation & Amortization (CF) of $194,000, down 24.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $215,000, down 19.2% from FY2025.

  • Depreciation & Amortization (CF) has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 39.3% (FY2021 to FY2026).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $266,000 in FY2025 (-5.0%), $280,000 in FY2024 (-4.4%), $293,000 in FY2023 (+106.3%) and $142,000 in FY2022 (+246.3%).
  • The fiscal Q1 2027 figure represents the lowest quarterly Depreciation & Amortization (CF) since fiscal Q3 2022.
  • Year-over-year, Depreciation & Amortization (CF) has declined for eight consecutive quarters, with an average decline of 17.0% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q2 2022 (growth of 750.0%), and the weakest in fiscal Q3 2024 (a decline of 45.4%).
  • Business Quant data shows VIVS's Depreciation & Amortization (CF) at $43,000 (Q4 2026), $52,000 (Q3 2026) and $59,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Iqvia Holdings 44.17 Bn 35.87 Bn 1.44 Bn 292.00 Mn
2 Medpace Holdings 17.45 Bn 15.51 Bn 201.64 Mn 6.56 Mn
3 Charles River Laboratories International 14.37 Bn 13.56 Bn 363.37 Mn 67.29 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn 90.77 Mn
5 Fortrea Holdings 2.12 Bn 1.50 Bn 139.20 Mn 19.60 Mn
6 Ginkgo Bioworks Holdings 625.60 Mn -136.48 Mn 18.44 Mn 12.32 Mn
7 Evotec SE 506.10 Mn -1.10 Bn - -
8 Champions Oncology 65.60 Mn 40.68 Mn 7.70 Mn 314,000.00
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn 190,775.50
10 VivoSim Labs 832,550.47 -16.89 Mn - 40,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40,000.00
Mar 31, 2026 43,000.00
Dec 31, 2025 52,000.00
Sep 30, 2025 59,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 61,000.00
Dec 31, 2024 67,000.00
Sep 30, 2024 68,000.00
Jun 30, 2024 70,000.00
Mar 31, 2024 71,000.00
Dec 31, 2023 71,000.00
Sep 30, 2023 71,000.00
Jun 30, 2023 67,000.00
Mar 31, 2023 59,000.00
Dec 31, 2022 130,000.00
Sep 30, 2022 54,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 46,000.00
Dec 31, 2021 37,000.00
Sep 30, 2021 34,000.00
API Access

VivoSim Labs Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VIVS&period=max&api_key=YOUR_API_KEY